" class="no-js "lang="en-US"> Wheeler Bio - Pharmtech Focus
Tuesday, January 31, 2023
Wheeler Bio | Pharmtech Focus

Wheeler Bio

About Wheeler Bio

Wheeler Bio
A disruptive new biopharmaceutical CDMO, we are pushing the boundaries of biomanufacturing and solving an outdated industry bottleneck with a unique partnering model. By bringing together biologics drug innovators, discovery CROs, and CDMOs, we are accelerating the translation of therapeutic innovation to clinical impact.

Related Story

Wheeler Bio Announces Roger Lias, Ph.D. as President and Chief Operating Officer

September 23 2022

Wheeler Bio, a new contract development and manufacturing organization (CDMO) specializing in the cell line […]